Compare Nora Therapeutics vs Opal Therapeutics
Customers evaluate the quality of Nora Therapeutics's products using the following success metrics.
Overview
Nora Therapeutics is based in United States
Nora Therapeutics is a privately-held biotechnology company focused on developing therapeutics to address IVF failure and recurrent pregnancy loss, two reproductive conditions with significant unmet need. Nora's lead compound, NT100, is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract and may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance. For more information, please visit www.noratherapeutics.com.
Opal Therapeutics is based in Australia
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
Demo Video
Leadership
Jeffrey Tong (Chief Executive Officer, President)
Stephen Kent (Founder)
Funding
Investors
Prospect Venture Partners, Vivo Capital
Alloy Ventures, Alta Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Nora Therapeutics has not claimed their profile.
Work for Nora Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Nora Therapeutics?
Claim your profile now.
Information not available because Opal Therapeutics has not claimed their profile.
Work for Opal Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Opal Therapeutics?
Claim your profile now.
News & Analysis
Nora Therapeutics has been mentioned in our research 1 time.
Opal Therapeutics has not been mentioned in our research.
Research Articles
